Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 65 results for "arun sawhney"

Sawhney assails NC, Cong for plundering public wealth

Excelsior Correspondent JAMMU, Nov 23: Independent candidate from Jammu West, Arun Sawhney, today attacked both NC and Congress for plundering public wealth openly and shamelessly. Addressing a public meeting at Bakshi Nagar, he came heavily on ... Daily, 2 months ago
Rehari residents felicitate Sat Sharma Daily, 3 weeks ago
GCOE organises Alumni meet Daily, 1 month ago

Obesity is rising in India. So are weight-loss surgeries.

NEW DELHI — These days, real estate developer Pradeep Sawhney ignores junk mail fliers from plus-size stores. Instead, he shows off his slim physique with designer duds, while sporting around New Delhi in a shiny, green BMW. Sawhney, 49, says ...
 Capital Bay2 days ago As obesity rises in India, so does weight-loss surgery  Washington Post2 days ago

Helios and Matheson's defaults and silence of regulators

Several depositors and investors are sending letters, notices to H&M for bounced cheques, while the company is reporting fabulous financial results and obtaining fancy ratings Chennai-based Helios and Matheson Information Technology (H&M), an ...
 Money Life4 days ago
Business Standard India

Ranbaxy announces launch of anti-malarial drug in African countries

Ranbaxy Laboratories Limited, a manufacturer of generic medicines, has received the regulatory approval to launch new chemical entity, or NCE, Synriam, an anti-malarial drug, in seven African countries namely Nigeria, Uganda, Senegal, Cameroon ...
 Individual.com3 weeks ago Ranbaxy receives approval for malaria drug Synriam from 7 African countries  Business Standard India1 month ago Ranbaxy to launch malaria drug in 7 African countries  Bio Spectrum Asia1 month ago Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries  MedIndia1 month ago

List of IAS and IPS officers allotted to Andhra Pradesh

Comments December 27, 2014 - Hyderabad These are the following IAS officers allotted to Andhra Pradesh. Indrajit Pal, RP Watal, IV Subba Rao, IYR Krishna Rao, J Ramanand, Satyanarayana Mohanty, Chirravuri Vishwanath, Satya Prakash Tucker, Ramesh ...
 AndhraNews.net4 weeks ago

Rollercoaster year paves way for an optimistic 2015

With less than a week to go before the curtains are down on 2014, the auto industry will have reason to feel hopeful about the road ahead. After all, there are favourable tailwinds such as a pro-business Government in place, gradual improvement in ...
 Hindu Business Line1 month ago

Ranbaxy Laboratories : Labs to take its novel drug Synriam to Africa

Mumbai : Drug manufacturer Ranbaxy Laboratories said that it has received regulatory approval to launch its new chemical entity (NCE) Synriam in seven African countries namely Nigeria , Uganda , Senegal , Cameroon , Guinea , Kenya and Ivory Coast .
 4 Traders1 month ago Ranbaxy gets nod to sell drug treating malaria in 7 African nations  DNA India1 month ago

Nifty ends above 8200, Sensex flat; HDFC up 5%, TCS dips 3%

03:30 pm Market closing Continuing its sluggish mode, the market ended flat. The Sensex was down 31.12 points at 27319.56 and the Nifty was down 4.50 points at 8219.60. About 1178 shares advanced, 1728 shares declined, and 108 shares were ...
 Moneycontrol.com1 month ago

Natco's CL for Nexavar survives Bayer's SLP

Natco has now won appeals at all three stages, from the the Intellectual Property Appellate Board (IPAB), High Court and now, the SC The Supreme Court of India (SC) has dismissed Bayer's Special Leave Petition (SLP) against India's first ...
 Financial Express1 month ago
International Business Times India

India,United States : CCI grants approval for SUN PHARMA and RANBAXY LABS merger [TendersInfo (India)]

The Competition Commission of India (CCI) has granted approval for the proposed merger between the Sun Pharma and Ranbaxy Labs. The merger will result in a combined entity with annual sales worth $4.3 billion, making it the fifth-largest generic ...
 Pharmacy Choice1 month ago Ranbaxy Posts Loss after Write-offs on US Import Bans  International Business Times India1 month ago CCI approves proposed merger between Sun Pharma and Ranbaxy  India Infoline1 month ago Ranbaxy and Sun Pharma merger approved  Pharmafocus1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less